Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug kinetics and artificial kidneys.

Literature DB >> 22417

Drug kinetics and artificial kidneys.

Abstract

The factors affecting solute movement across the membrane during haemodialysis are well understood. Likewise the mathematics of drug kinetics are well described. However, studies of the effects of artificial kidneys on drug kinetics have often been limited by a lack of attention to proper methods of calculating solute clearance by the artificial kidney.

Mesh：

Substances：

Year: 1977 PMID： 22417 DOI： 10.2165/00003088-197702060-00002

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

224 in total

1. Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man.

Authors: J A Clements; L F Prescott
Journal: J Pharm Pharmacol Date: 1976-09 Impact factor: 3.765

2. CEPHALOTHIN SERUM LEVELS IN THE AZOTEMIC PATIENT.

Authors: S A KABINS; S COHEN
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1964

3. Streptomycin in the blood; chemical determinations after single and repeated intramuscular injections.

Authors: G E BOXER; V C JELINEK
Journal: J Pharmacol Exp Ther Date: 1948-03 Impact factor: 4.030

4. Clinical pharmacology of amikacin and kanamycin.

Authors: W M Kirby; J T Clarke; R D Libke; C Regamey
Journal: J Infect Dis Date: 1976-11 Impact factor: 5.226

5. Pharmacokinetics of oral propranolol in chronic renal disease.

Authors: D T Lowenthal; W A Briggs; T P Gibson; H Nelson; W J Cirksena
Journal: Clin Pharmacol Ther Date: 1974-11 Impact factor: 6.875

6. Kinetics of ethambutol elimination in renal disease.

Authors: T G Christopher; A Blair; A Forrey; R E Cutler
Journal: Proc Clin Dial Transplant Forum Date: 1973

7. Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration.

Authors: M Ehrnebo
Journal: J Pharm Sci Date: 1974-07 Impact factor: 3.534

8. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Authors: I Odar-Cederlöf; O Borgå
Journal: Eur J Clin Pharmacol Date: 1974 Impact factor: 2.953

9. Absorption of rifampin from various preparations and pharmaceutic forms.

Authors: P Männistö
Journal: Clin Pharmacol Ther Date: 1977-03 Impact factor: 6.875

10. Pharmacokinetics of methyldopa in man.

Authors: K C Kwan; E L Foltz; G O Breault; J E Baer; J A Totaro
Journal: J Pharmacol Exp Ther Date: 1976-08 Impact factor: 4.030

26 in total

Review 1. A review of drug prescribing in children with end-stage renal failure.

Authors: R S Trompeter
Journal: Pediatr Nephrol Date: 1987-04 Impact factor: 3.714

Review 2. Pharmacokinetics of haemoperfusion for drug overdose.

Authors: S Pond; J Rosenberg; N L Benowitz; S Takki
Journal: Clin Pharmacokinet Date: 1979 Sep-Oct Impact factor: 6.447

Review 3. Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors: J C Pechere; R Dugal
Journal: Clin Pharmacokinet Date: 1979 May-Jun Impact factor: 6.447

Review 4. Drug prescribing in renal failure.

Authors: W M Bennett
Journal: Drugs Date: 1979-02 Impact factor: 9.546

Review 5. Clinical relevance of pharmacokinetics.

Authors: G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal: Clin Pharmacokinet Date: 1980 Mar-Apr Impact factor: 6.447

6. Alteration of drug-protein binding in renal disease.

Authors: M M Reidenberg; D E Drayer
Journal: Clin Pharmacokinet Date: 1984-01 Impact factor: 6.447

7. Pharmacokinetic evaluation of haemoperfusion in phenobarbital poisoning.

Authors: D Jacobsen; E Wiik-Larsen; T Dahl; E Enger; P K Lunde
Journal: Eur J Clin Pharmacol Date: 1984 Impact factor: 2.953

8. Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal.

Authors: W R Gillespie; P Veng-Pedersen; M J Berg; D D Schottelius
Journal: J Pharmacokinet Biopharm Date: 1986-02

9. Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis.

Authors: D R Guay; R C Meatherall; H Baxter; W R Jacyk; B Penner
Journal: Antimicrob Agents Chemother Date: 1984-03 Impact factor: 5.191

10. Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.

Authors: M V Mac-Kay; J Sanchez Burson; J Martinez-Lanao; A Dominguez-Gil
Journal: Clin Pharmacokinet Date: 1993-09 Impact factor: 6.447